PCN

NYSE Pimco Corporate & Income Strategy Fund
Oct 5, 2026 · 1:36 PM ET DELAYED Market Open

$10.68 ↓ -0.19 (-1.79%) Trading Down from the previous close of $10.87, $0.21 below the day’s high of $10.88

YTD change
-16.34%
vs 20-day SMA
-3.76%
vs 200-day SMA
-11.06%

Price ranges

Previous day
$10.74 $10.91
open $10.77 close $10.87
+$0.10 (+0.93%)
Today
$10.66 $10.88
open $10.88 now $10.68
-$0.21 (-1.88%)
Past week
$10.44 $10.91
from $10.78 now $10.68
-$0.10 (-0.97%)
Past month
$10.44 $11.80
from $11.67 now $10.68
-$0.99 (-8.53%)
This year
$10.44 $12.90
from $12.76 now $10.68
-$2.09 (-16.34%)

Price & Performance

-1.16 (-9.64%) / 6M

$10.48$11.07$11.67$12.26Apr 6Jul 6Oct 2

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 47.3% away from all-time highs of $20.25
  • PCN is down 16% since the beginning of the year
  • PCN is down 20% over the past 12 months
  • PCN is down 9% over the past 1 month

PCN reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -19.0%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable N/A
EPS N/A
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A

Balance sheet & scale

IncomeN/A
RevenueN/A
CashN/A
DebtN/A
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNYSE
Sector Finance and Insurance
Sub Sector Funds, Trusts, and Other Financial Vehicles
Market cap $374.8M

Competitor comparison

TickerCompany PriceChange
PGPHF Partners Group Holding AG $730.00 -3.33%
SEGXF SEGRO plc $12.00 -4.00%
PHYS.U.CAT SPROTT PHYSICAL GOLD TRUST USD $31.17 -0.95%
CPAMF CapitaLand Integrated Commercial Trust $1.75 +0.00%
NLY Annaly Capital Management, Inc. $18.50 -1.07%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.